Venture Capital Panelist Presentation Slides - Chbmr.com

Recommendations

Info

• Life Sciences – R&D Partnering in drug development and diagnostics – In-licensing and out-licensing of therapeutic and diagnostic technologies – Funding sources Opportunities – Technology Partnering Missions – Good conferences to present your technology- MassBio, MedTech Investor Conference
Life Sciences Connections • 500 biotechnology companies • Big Pharma & Big Bio: Merck, Novartis, Pfizer, Astra- Zeneca, Genzyme, Amgen, Biogen, Sanofi, GSK • NIH-funded universities, teaching hospitals and research institutions • 475 medical device companies include: Boston Scientific, J&J, Covidien • Angels, Venture Capital firms, funds, venture debt finance companies
Page 1 and 2: Christine Sarkisian Trade Commissio
Page 3 and 4: The New England Economy • Thrives
Page 5 and 6: The Consulate’s Priority Sectors
Page 7 and 8: Virtual Trade Commissioner Powerful
Page 9 and 10: Opportunities • Agriculture, Food
Page 11: Opportunities • Ocean Technologie
Page 15 and 16: Our Team Consul General Pat Binns M
Page 17 and 18: Dr. Peter Farina Canaan Partners
Page 19 and 20: OVERVIEW About Canaan Partners » 2
Page 21 and 22: Areas of Interest » Biologics & Sm
Page 23 and 24: Typical Investment » Phase I or Ph
Page 25 and 26: Canaan Investment Model » Canaan u
Page 27 and 28: Dr. Luc Marengère VenGrowth Partne
Page 29 and 30: VG Partners Life Sciences Team Team
Page 31 and 32: VG Partners Life Sciences Team Four
Page 33 and 34: Our track record - Capital Leverage
Page 35 and 36: VG Partners: Our Value-Add VisualSo
Page 37 and 38: Creating Sustainable Value Luc Mare
Page 39 and 40: Synergy Partners International Syne
Page 41 and 42: Synergy Interests Cancer Therapy an
Page 43 and 44: Representative Portfolio Companies
Page 45 and 46: TVM Capital Life Sciences Practice
Page 47 and 48: TVM Capital life science profile
Page 49 and 50: Creating substantial companies Sour
Page 51 and 52: Long-term stability paired with gro
Page 53 and 54: Projected Growth of Large Pharmaceu
Page 55 and 56: Two Emerging Strategies In Life Sci
Page 57 and 58: Tom Hayes GrowthWorks Atlantic Ltd
Page 59 and 60: GrowthWorks Overview � GrowthWork
Page 61 and 62: Retail venture capital (RVC) � Ra
Page 63 and 64:
Contributions from Provincial Treas
Page 65 and 66:
GWA Portfolio Companies Company Sec
Page 67 and 68:
Dr. Christian Cortis Advanced Techn
Page 69 and 70:
69 ATV OVERVIEW � Now in its 30 t
Page 71 and 72:
71 Characteristics of Compelling In
Page 73 and 74:
73 Recent Life Science Investments
Page 75 and 76:
Hercules Technology Growth Capital
Page 77 and 78:
HTGC Life Science Underwriting Guid
Page 79 and 80:
79 Life Sciences Portfolio at a Gla
show all

Venture Capital Panelist Presentation Slides - Chbmr.com

Create successful ePaper yourself

Delete template?

Save as template?